abstract |
The following compounds of formula (I) are disclosed. The compounds of the present invention bind to the CB2 receptor and are agonists, antagonists or inverse agonists of the CB2 receptor and are useful for the treatment of inflammation. The compounds that are agonists are further useful for the treatment of pain. [Chemical 1] (I) [Selection figure] None |